Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

Charles HervochonBenjamin HennartAnne-Gaëlle LeroyStéphane Corvec David Boutoille Eric M SennevilleAlbert SottoGabriella IllesPascal ChavanetVincent DubéeAlexandre BleibtreuMarie-Charlotte De CarnéJean-Philippe TalarminMatthieu RevestBernard CastanRonan BellouardÉric DaillyDelphine AllorgeAurélien DinhPaul Le TurnierMatthieu Gregoire

Published in: The Journal of antimicrobial chemotherapy (2023)

Plasma concentrations of dalbavancin were consistent with those described in clinical trials and those sought during the industrial development of the molecule.

Keyphrases

clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
randomized controlled trial
heavy metals
wastewater treatment
risk assessment
study protocol